Tutorials
Chinook Therapeutics Inc logo

Chinook Therapeutics Inc

$ 20.44 +0.07 (+0.34%) 10:08 PM EST
P/E:
At Loss
P/B:
2.64
Market Cap:
$ 1.26B
Enterprise V:
$ 1.03B
Volume:
673.40K
Avg Vol (2M):
594.53K
Also Trade In:
Volume:
673.40K
Market Cap $:
1.26B
PE Ratio:
At Loss
Avg Vol (2-Month):
594.53K
Enterprise Value $:
1.03B
PB Ratio:
2.64
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download Tutorials

Business Description

Chinook Therapeutics Inc
NAICS : 541714 SIC : 2834
400 Fairview Avenue North, Suite 900, Seattle, WA, USA, 98109
Description
Chinook Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing precision medicines for kidney diseases. The products of the company are focused on rare, severe chronic kidney disorders.
Name Current Vs Industry Vs History
Cash-To-Debt 6.42
Equity-to-Asset 0.8
Debt-to-Equity 0.1
Debt-to-EBITDA -0.61
Interest Coverage N/A
N/A
N/A
Piotroski F-Score N/A/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 6.62
Distress
Grey
Safe
Beneish M-Score 37.26
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 80.63
9-Day RSI 71.38
14-Day RSI 66.09
6-1 Month Momentum % 45.2
12-1 Month Momentum % 45.43

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 7.82
Quick Ratio 7.82
Cash Ratio 7.55
Days Sales Outstanding 18.59

Dividend & Buy Back

Name Current Vs Industry Vs History

Profitability Rank

Name Current Vs Industry Vs History
Operating Margin % -139.87
Net Margin % -180.48
ROE % -27.87
ROA % -21.31
ROIC % -33.68
ROC (Joel Greenblatt) % -102.13
ROCE % -17.67

Financials (Next Earnings Date:2022-08-12 Est.)

KDNY's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:KDNY

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 53.971
EPS (TTM) ($) -2.06
Beta 0
Volatility % 66.33
14-Day RSI 66.09
14-Day ATR ($) 0.990129
20-Day SMA ($) 18.724
12-1 Month Momentum % 45.43
52-Week Range ($) 10.48 - 21.11
Shares Outstanding (Mil) 61.61

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9999
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Chinook Therapeutics Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More